Scott Fisher, M.D. is a Board-Certified Psychiatrist and Lead Facilitator & Clinical Program Manager at Segal Trials’ Center for Psychedelic Research located in Lauderhill, FL. His work has included Phase 2 and 3 FDA clinical studies of psilocybin, LSD, and 5-MeO-DMT for the treatment of depression and anxiety disorders. He received his medical degree from The Feinberg School of Medicine at Northwestern University in 2009 and is one of only few licensed psychiatrists in the country with advanced certification in Psychedelic-assisted psychotherapy from California Institute of Integral Studies, the only accredited institution of higher learning in this field.In todays discussion we take a trip through magic mushrooms, LSD and DMT, touching upon how they impact the user at the level of psychology, then biology, specifically: neural networks and neurotransmitters. We discuss his role as a facilitator in psychedelic trials, what one might expect if they were to join a study and the progress their trials are making in relationship to their use in the treatment of anxiety and depression. Several interesting subjects are discussed, such a Mckennas stoned ape hypothesis, Meetings with machine elves, and whether psychedelics enable us to view reality with more accuracy. As usual we end with a round of rapid fire questions. Feel free to skip around if you find any of these topics of interest to you. If you are interested in participating in trials: www.segaltrials.comMy website: drchancnc.comInstagram: @draldrichanBooks: Reassembling Models of Reality: https://a.co/d/9s6Qu2J